from24/7 Wall St.1 week agoNovo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (July 2025)Ozempic is projected to achieve $17 billion in sales for 2024 and almost $5 billion in the first quarter of 2025, highlighting its commercial success.Healthcare
HealthcarefromNature1 month agoObesity drugs made in China could power next wave of treatmentsEcnoglutide is a promising next-generation obesity drug developed in China, showing significant advantages over placebo in weight loss.
US newsfromwww.npr.org1 month agoA new chapter for online sales of obesity drug alternatives tests legal limitsChris Spears launched OrderlyMeds to provide compounded obesity drug alternatives after struggling to find prescribed medication.
fromwww.cbc.ca2 months agoWellnessWeightWatchers files for bankruptcy after weight-loss drugs capsized industry | CBC NewsWW International has filed for Chapter 11 bankruptcy to reduce its debt due to competition from new obesity medications.
fromNew York Post2 months agoWellnessWeightWatchers files for bankruptcy amid rising use of Ozempic, other obesity drugsWW International has filed for Chapter 11 bankruptcy due to rising competition from obesity drugs that undermined its traditional business model.
fromwww.cbc.ca2 months agoWellnessWeightWatchers files for bankruptcy after weight-loss drugs capsized industry | CBC News
WellnessfromNew York Post2 months agoWeightWatchers files for bankruptcy amid rising use of Ozempic, other obesity drugsWW International has filed for Chapter 11 bankruptcy due to rising competition from obesity drugs that undermined its traditional business model.
